Bionano Genomics, Inc. Operating Lease Cost
Bionano Genomics, Inc. (BNGO) reported Operating Lease Cost of $1.52 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-23
- Bionano Genomics, Inc. operating lease, cost for fiscal 2025 was $1.52M, a 42.36% decline from fiscal 2024.
- Bionano Genomics, Inc. operating lease, cost for fiscal 2024 was $2.63M, a 1.16% decline from fiscal 2023.
- Bionano Genomics, Inc. operating lease, cost for fiscal 2023 was $2.66M, a 27.78% increase from fiscal 2022.
- Bionano Genomics, Inc. operating lease, cost for fiscal 2022 was $2.08M, a 86.40% increase from fiscal 2021.
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $1.52M 10-K · filed 2026-03-23 |
| 2024-12-31 | $2.63M 10-K · filed 2026-03-23 |
| 2023-12-31 | $2.66M 10-K · filed 2025-03-31 |
| 2022-12-31 | $2.08M 10-K · filed 2024-03-05 |
| 2021-12-31 | $1.12M 10-K · filed 2023-03-09 |
| 2020-12-31 | $887.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |